Stroke remains one of the leading causes of disability and death worldwide, necessitating prompt recognition and management by healthcare professionals. This guide aims to enhance understanding of early stroke signs and provide a comprehensive approach to its management.
Early recognition of stroke is crucial in mitigating its devastating consequences. The acronym FAST (Face drooping, Arm weakness, Speech difficulty, Time to call emergency services) helps identify stroke signs swiftly. However, other less obvious signs such as sudden confusion, trouble seeing, dizziness, or severe headache should not be overlooked. Healthcare providers should maintain a high index of suspicion, particularly for at-risk patients.
Upon suspicion of stroke, immediate activation of the stroke pathway is essential. The patient should be rapidly assessed using a validated stroke scale such as the NIH Stroke Scale. Concurrently, urgent neuroimaging, preferably a CT scan, should be performed to differentiate between ischemic and hemorrhagic stroke, guiding further management.
Ischemic strokes, accounting for approximately 87% of all strokes, necessitate urgent reperfusion therapy. Intravenous thrombolysis with recombinant tissue plasminogen activator (rtPA) can be administered within 4.5 hours from symptom onset. Endovascular thrombectomy may be considered for patients with large vessel occlusion and within 24 hours of symptom onset.
Hemorrhagic strokes require careful control of blood pressure, correction of coagulopathy, and neurosurgical consultation. In intracerebral hemorrhages, surgical evacuation may be necessary, while aneurysmal subarachnoid hemorrhages may require coiling or clipping.
Early recognition and prompt management of stroke can significantly reduce morbidity and mortality. Healthcare professionals play a pivotal role in this process, and a thorough understanding of early stroke signs and management principles is essential in providing optimal patient care.
1.
Mosunetuzumab in Follicular Lymphoma: Durable Responses and Manageable Safety
2.
As EGFR internalization is decreased, BUB1 controls EGFR signaling.
3.
Getting Lung Cancer Screening Staff Involved Improved Tobacco Cessation
4.
Low Income, Education Tied to Depression in Older Adults
5.
In Higher-Risk MDS, CMML, All-Oral Therapy Has Promise.
1.
Bridging Disciplines: Medical Oncology vs Surgical Oncology in the Era of Multidisciplinary Cancer Care
2.
Next-Gen CAR Cell Therapies in Oncology: Frontiers in Solid Tumors & Hematologic Malignancies
3.
Next-Generation Sequencing in Oncology: Unlocking the Future of Precision Medicine
4.
Unlocking the Key to Treating Lymphoma: New Innovations in Cancer Research
5.
Personalizing Cancer Care: Microbiome Advances, Challenges, and Future Directions
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma - Part VI
2.
Targeting Oncologic Drivers: A New Approach to Lung Cancer Treatment
3.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part IV
4.
Managing CNS diseases at the point of diagnosis in ALK + NSCLC
5.
Navigating the Complexities of Ph Negative ALL - Part XV
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation